P21 Peptide corresponds to a regulatory-motif fragment frequently employed to study small GTPase interactions and signaling complexes. Its sequence encodes recognition elements for effector binding and conformational switching. Researchers use it to dissect protein-protein interaction surfaces and competition patterns. Applications include signaling-pathway dissection, peptide-inhibitor design, and structural-biology workflows.
CAT No: R2725
P21 Peptide is a synthetic peptide fragment derived from the amino acid sequence of the cyclin-dependent kinase inhibitor p21^Cip1/Waf1, a key regulator of the cell cycle. As a biologically active peptide, it plays a crucial role in modulating cellular proliferation, differentiation, and DNA damage response pathways. Its unique sequence allows it to interact with a variety of molecular targets, making it a valuable tool for dissecting cell cycle checkpoints, apoptosis mechanisms, and protein-protein interactions in both basic and applied biochemical research. The functional relevance of this peptide extends to studies of tumor suppressor pathways, signal transduction, and cellular stress responses, positioning it as an indispensable reagent for researchers investigating cell cycle dynamics and related molecular processes.
Cell Cycle Regulation Studies: In the context of cell biology research, P21 Peptide is widely employed to interrogate the mechanisms underlying cell cycle arrest and checkpoint control. By mimicking the functional domains of endogenous p21, it can be used to inhibit cyclin-dependent kinase (CDK) activity in vitro, thereby facilitating the study of G1/S and G2/M phase transitions. Researchers utilize this peptide to elucidate how p21-mediated inhibition of CDK-cyclin complexes contributes to cell cycle arrest in response to DNA damage or oncogenic stress, providing mechanistic insights into cell proliferation control and tumor suppressor functions.
Protein-Protein Interaction Mapping: The peptide serves as a valuable probe for investigating the molecular interactions between p21 and its binding partners, such as CDKs and proliferating cell nuclear antigen (PCNA). By incorporating P21 Peptide into binding assays, pull-down experiments, or surface plasmon resonance studies, investigators can characterize the affinity and specificity of p21 interactions, map critical contact residues, and explore the structural determinants of these complexes. Such applications are essential for understanding the regulatory networks controlling DNA replication, repair, and cell cycle progression.
Apoptosis and Stress Response Research: P21 Peptide is also utilized in studies examining the cellular response to genotoxic stress and the induction of programmed cell death. Its ability to modulate CDK activity and interact with apoptotic regulators allows researchers to dissect the signaling pathways that determine cellular fate following DNA damage. Experimental systems incorporating this peptide help clarify the crosstalk between cell cycle arrest and apoptosis, enabling the identification of novel molecular targets for modulating stress responses in cellular models.
Peptide-Based Screening and Inhibitor Development: In drug discovery and chemical biology, P21 Peptide provides a functional template for the design and screening of small-molecule inhibitors or mimetics targeting the p21-CDK interface. Researchers employ the peptide in high-throughput assays to evaluate the efficacy of candidate compounds in disrupting or enhancing these protein-protein interactions. Such studies support the rational development of molecules with potential applications in modulating cell cycle progression and investigating the biochemical basis of cell proliferation disorders.
Signal Transduction Pathway Elucidation: The peptide is frequently incorporated into experimental models aimed at deciphering the broader signaling cascades influenced by p21 activity. By introducing P21 Peptide into cell-free systems or cellular extracts, scientists can monitor downstream effects on phosphorylation events, transcriptional regulation, and checkpoint activation. These approaches enable a detailed analysis of how p21 integrates signals from upstream pathways, such as p53 or growth factor signaling, into coordinated cellular responses, advancing our understanding of cell cycle control at the systems level.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More